Vermillion ROA 2006-2018 | VRML

Current and historical return on assets (ROA) values for Vermillion (VRML) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Vermillion ROA for the three months ending September 30, 2018 was -108.24%.
Vermillion ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.01B $0.01B -117.07%
2018-06-30 $-0.01B $0.02B -126.32%
2018-03-31 $-0.01B $0.01B -146.67%
2017-12-31 $-0.01B $0.01B -125.71%
2017-09-30 $-0.01B $0.01B -122.22%
2017-06-30 $-0.01B $0.01B -118.92%
2017-03-31 $-0.01B $0.01B -120.93%
2016-12-31 $-0.02B $0.01B -122.45%
2016-09-30 $-0.02B $0.01B -109.68%
2016-06-30 $-0.02B $0.01B -100.00%
2016-03-31 $-0.02B $0.02B -108.11%
2015-12-31 $-0.02B $0.02B -98.70%
2015-09-30 $-0.02B $0.03B -90.00%
2015-06-30 $-0.02B $0.01B -104.11%
2015-03-31 $-0.02B $0.02B -94.12%
2014-12-31 $-0.02B $0.02B -86.02%
2014-09-30 $-0.02B $0.02B -72.00%
2014-06-30 $-0.01B $0.02B -57.73%
2014-03-31 $-0.01B $0.03B -44.44%
2013-12-31 $-0.01B $0.03B -51.43%
2013-09-30 $-0.01B $0.02B -66.67%
2013-06-30 $-0.01B $0.02B -64.00%
2013-03-31 $-0.01B $0.01B -61.54%
2012-12-31 $-0.01B $0.01B -42.42%
2012-09-30 $-0.01B $0.02B -45.00%
2012-06-30 $-0.01B $0.02B -52.75%
2012-03-31 $-0.02B $0.02B -58.72%
2011-12-31 $-0.02B $0.02B -55.81%
2011-09-30 $-0.02B $0.03B -58.46%
2011-06-30 $-0.02B $0.04B -53.13%
2011-03-31 $-0.01B $0.04B -52.75%
2010-12-31 $-0.02B $0.02B -160.00%
2010-09-30 $-0.02B $0.03B -283.87%
2010-06-30 $-0.03B $0.00B -2400.00%
2010-03-31 $-0.03B $0.00B -2480.00%
2009-12-31 $-0.02B $0.01B -1760.00%
2009-09-30 $-0.02B $0.00B inf%
2009-06-30 $-0.01B $0.00B -800.00%
2009-03-31 $-0.02B $0.00B -320.00%
2008-12-31 $-0.02B $0.00B -189.47%
2008-09-30 $-0.02B $0.01B -109.68%
2008-06-30 $-0.02B $0.01B -82.93%
2008-03-31 $-0.02B $0.02B -97.56%
2007-12-31 $-0.02B $0.02B -102.44%
2007-09-30 $-0.02B $0.03B -98.77%
2007-06-30 $-0.02B $0.01B -98.88%
2007-03-31 $-0.02B $0.02B -78.63%
2006-12-31 $-0.02B $0.02B -60.27%
2006-09-30 $-0.03B $0.04B -68.18%
2006-06-30 $-0.03B $0.04B -59.70%
2006-03-31 $-0.03B $0.05B -57.94%
2005-12-31 $-0.04B $0.05B -61.14%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.100B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.149B 23.70
Intuitive Surgical (ISRG) United States $64.544B 60.29
Edwards Lifesciences (EW) United States $39.661B 40.62
Fresenius Medical Care AG KGaA (FMS) Germany $24.173B 16.55
IDEXX Laboratories (IDXX) United States $18.555B 50.53
ABIOMED (ABMD) United States $15.025B 99.18
Teleflex (TFX) United States $13.856B 30.38
Hologic (HOLX) United States $13.744B 20.78
DexCom (DXCM) United States $13.154B 503.96
Varian Medical Systems (VAR) United States $12.307B 30.74
STERIS (STE) United Kingdom $10.424B 26.79
Masimo (MASI) United States $7.034B 43.79
Penumbra (PEN) United States $5.275B 298.45
Integra LifeSciences Holdings (IART) United States $4.747B 23.02
Globus Medical (GMED) United States $4.684B 28.43
LivaNova (LIVN) United Kingdom $4.643B 28.38
Tandem Diabetes Care (TNDM) United States $4.116B 0.00
Wright Medical Group (WMGI) Netherlands $4.048B 0.00
Cantel Medical (CMD) United States $2.797B 27.81
Integer Holdings (ITGR) United States $2.795B 22.80
Glaukos (GKOS) United States $2.642B 0.00
Inogen (INGN) United States $2.088B 41.61
AVANOS MEDICAL, INC (AVNS) United States $2.041B 22.17
OPKO Health (OPK) United States $1.551B 0.00
Nevro (NVRO) United States $1.349B 0.00
Tactile Systems Technology (TCMD) United States $1.170B 222.11
Pacific Biosciences Of California (PACB) United States $1.110B 0.00
CryoLife (CRY) United States $1.099B 118.44
Accelerate Diagnostics (AXDX) United States $1.089B 0.00
Luminex (LMNX) United States $1.072B 48.98
ORTHOFIX MEDICAL INC (OFIX) United States $1.071B 29.11
Intersect ENT (XENT) United States $1.036B 0.00
Natus Medical (BABY) United States $0.913B 19.03
Mesa Laboratories (MLAB) United States $0.898B 36.74
Veracyte (VCYT) United States $0.898B 0.00
AxoGen (AXGN) United States $0.837B 0.00
AngioDynamics (ANGO) United States $0.814B 26.40
ViewRay (VRAY) United States $0.790B 0.00
OrthoPediatrics (KIDS) United States $0.661B 0.00
Quotient (QTNT) Switzerland $0.613B 0.00
Fluidigm (FLDM) United States $0.543B 0.00
TransEnterix (TRXC) United States $0.510B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.475B 50.03
Si-Bone (SIBN) United States $0.459B 0.00
Accuray (ARAY) United States $0.410B 0.00
GenMark Diagnostics (GNMK) United States $0.408B 0.00
Corindus Vascular Robotics (CVRS) United States $0.385B 0.00
Pulse Biosciences (PLSE) United States $0.378B 0.00
RTI Surgical (RTIX) United States $0.370B 54.00
Neuronetics (STIM) United States $0.296B 0.00
IRadimed (IRMD) United States $0.281B 59.42
SeaSpine Holdings (SPNE) United States $0.273B 0.00
Sientra (SIEN) United States $0.269B 0.00
Nuvectra (NVTR) United States $0.225B 0.00
CRH Medical (CRHM) Canada $0.210B 48.67
Helius Medical Technologies (HSDT) United States $0.160B 0.00
Ekso Bionics Holdings (EKSO) United States $0.159B 0.00
Biosig Technologies (BSGM) United States $0.137B 0.00
Sensus Healthcare (SRTS) United States $0.130B 0.00
ConforMIS (CFMS) United States $0.127B 0.00
Alphatec Holdings (ATEC) United States $0.119B 0.00
T2 Biosystems (TTOO) United States $0.118B 0.00
Second Sight Medical Products (EYES) United States $0.104B 0.00
SOLITON INC (SOLY) $0.091B 0.00
EDAP TMS (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.072B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.068B 0.00
Ra Medical Systems (RMED) United States $0.051B 0.00
Avinger (AVGR) United States $0.044B 0.00
Electromed (ELMD) United States $0.044B 22.83
Xtant Medical Holdings (XTNT) United States $0.041B 0.00
OBALON THERPTCS (OBLN) United States $0.039B 0.00
Restoration Robotics (HAIR) United States $0.035B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Viveve Medical (VIVE) United States $0.030B 0.00
PAVmed (PAVM) United States $0.029B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.026B 0.00
Atossa Genetics (ATOS) United States $0.025B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
Bioanalytical Systems (BASI) United States $0.019B 63.02
Dynatronics (DYNT) United States $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
Presbia (LENS) Ireland $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Neovasc (NVCN) Canada $0.013B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00